Pharmaron’s UK Radiolabeled Science sites include the following service offerings:
1. 14C (GMP/non-GMP) & 3H Radiolabeling and radiosynthesis projects
2. In Vivo DMPK/ADME studies (e.g. QWBA/MARG, Met ID, etc.)
3. In Vitro DMPK/ADME studies
4. Environmental Fate and Pharma risk assessment
5. BioAnalysis and AMS (Accelerator Mass Spectrometry)

No other radiosynthesis CRO has a more experienced team with over 60 years radiolabeling more than 70,000 different 14C and 20,000 different 3H molecules, the most sheer numbers of any commercial vendor. Our synthetic chemists, analytical chemists and drug metabolism scientists synthesize and use 14C and 3H radiolabeled compounds to study the absorption, distribution, metabolism, excretion (ADME) and fate of a wide variety of compounds, including peptides (wet & dry chemistry), oligonucleotides, polymers, ADC’s, chiral synthesis or separation, and even fermentations, in clinical, preclinical, and discovery investigations.